Strides Pharma Science Ltd - 532531 - Intimation To Members About Annual General Meeting Of The Company And Record Date For The Purpose Of Final Dividend
Sub: Intimation to Members about Annual General Meeting of the Company and Record Date for the purpose of Final Dividend China to delist record number of firms to ensure 'survival of the fittest'
China has introduced a US-style system to make listing easier for Shenzhen's start-up board ChiNext. The system was first adopted by Shanghai's tech-focused STAR Market Strides Pharma Surges On USFDA Nod For Headache Drug
Strides Pharma shares surged as much as 5% after it got approval from USFDA for Butalbital, Acetaminophen, Caffeine, andCodeine Phosphate Capsules. Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides receives USFDA approval for Butalbital,Acetaminophen, Caffeine, and Codeine Phosphate Capsules Strides Pharma Science Ltd - 532531 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 26, 2020 for Chayadeep Properties Pvt Ltd Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 24, 2020 for Lifecell International Pvt Ltd Strides Pharma Science Ltd - 532531 - Corporate Action-Updates on Amalgamation/ Merger / Demerger
Order of the National Company Law Tribunal, Bengaluru Bench sanctioning merger of wholly owned subsidiaries Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 18, 2020 for Chayadeep Properties Pvt Ltd Strides Pharma Science Ltd - 532531 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to above, please find enclosed the disclosure of Related Party Transactions, on consolidated basis, for the half year ended March 31, 2020 drawn in accordance with applicable accounting standards. Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Issue of duplicate share certificate under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015